In summary, this study revealed that LRP5 overexpression in bone cells significantly inhibited breast cancer cell proliferation, migration, and invasion, and regulated osteoclast differentiation and immune response by activating the LIMA1/MYO5B signaling axis. Here, LIMA1 is linked to breast carcinoma.